99mTc-technetium labeling of antiarthritic peptides to evaluate homing and biodistribution at inflamed joints

Nuclear Medicine and Biology

Volumn 38, Issue 5, 2011, Pages 751-756

  Ali, Marina ^a   Vanniasinghe, Anne ^a   Kumar, Vijay ^a   Barnett, Robert ^a   Alberto, Roger ^b   Manolios, Nicholas ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Arthritis; Drug delivery; Peptides; Radiolabeling

Indexed keywords

ANTIRHEUMATIC AGENT; CORE PEPTIDE; CORE PEPTIDE HAP 1 PEPTIDE CONJUGATE; HAP 1 PEPTIDE; TECHNETIUM 99M; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; OLIGOPEPTIDE; TECHNETIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG LABELING; DRUG PURITY; DRUG SCREENING; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; GAMMA SCINTIGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MASS SPECTROMETRY; MOLECULAR IMAGING; NONHUMAN; RAT; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECT; FEMALE; INFLAMMATION; METABOLISM; MOLECULAR GENETICS; PROTEIN TRANSPORT; SYNOVIUM; WISTAR RAT;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS; FEMALE; INFLAMMATION; ISOTOPE LABELING; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN TRANSPORT; RATS; RATS, WISTAR; SYNOVIAL MEMBRANE; TECHNETIUM;

EID: 79959628856     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.01.007     Document Type: Article

References (19)

1. Harris E. Kelleys textbook of rheumatology 2005, Elisevier Saunders, Philadelphia.
2. Ellerby H.M., Arap W., Ellerby L.M., Kain R., Andrusiak R., Del Rio G., et al. Anti-cancer activity of targeted proapoptotic peptides. Nat Med 1999, 5:1032-1038.
3. Ellerby H.M., Bredesen D.E., Fujimura S., John V. Hunter-killer peptide (HKP) for targeted therapy. J Med Chem 2008, 51:5887-5892.
4. Gerlag D.M., Borges E., Tak P.P., Ellerby H.M., Bredesen D.E., Pasqualini R., et al. Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res 2001, 3:357-361.
5. Manolios N., Collier S., Taylor J., Pollard J., Harrison L.C., Bender V. T-cell antigen receptor transmembrane peptides modulate T-cell function and T-cell mediated disease. Nat Med 1997, 3:84-88.
6. Amon M.A., Ali M., Bender V., Chang Y.N., Toth I., Manolios N. Lipidation and glycosylation of a T-cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. Biochim Biophys Acta 2006, 1763:879-888.
7. Gollner G.P., Muller G., Alt R., Knop J., Enk A.H. Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases. Gene Ther 2000, 7:1000-1004.
8. Mi Z., Lu X., Mai J.C., Ng B.G., Wang G., Lechman E.R., et al. Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium. Mol Ther 2003, 8:295-305.
9. Bansal P.S., Torres A.M., Crossett B., Wong K.K., Koh J.M., Geraghty D.P., et al. Substrate specificity of platypus venom l-to-d-peptide isomerase. J Biol Chem 2008, 283:8969-8975.
10. Pak J.K., Benny P., Spingler B., Ortner K., Alberto R. N(epsilon) functionalization of metal and organic protected L-histidine for a highly efficient, direct labeling of biomolecules with [Tc(OH2)3(CO)3]+. Chemistry 2003, 9:2053-2061.
11. Bender V., Ali M., Amon M., Diefenbach E., Manolios N. T cell antigen receptor peptide-lipid membrane interactions using surface plasmon resonance. J Biol Chem 2004, 279:54002-54007.
12. Alberto R., Ortner K., Wheatley N., Schibli R., Schubiger A.P. Synthesis and properties of boranocarbonate: a convenient in situ CO source for the aqueous preparation of [(99m)Tc(OH(2))3(CO)3]+. J Am Chem Soc 2001, 123:3135-3136.
13. Mottonen T.T., Hannonen P., Toivanen J., Rekonen A., Oka M. Scintigraphy of rheumatoid peripheral joints. Reliability of visual assessment vs. computerized methods. Scand J Rheumatol 1987, 16:421-427.
14. Goins B., Klipper R., Rudolph A.S., Cliff R.O., Blumhardt R., Phillips W.T. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J Nucl Med 1993, 34:2160-2168.
15. Zinn K.R., Chaudhuri T.R., Smyth C.A., Wu Q., Liu H.G., Fleck M., et al. Specific targeting of activated endothelium in rat adjuvant arthritis with a 99mTc-radiolabeled E-selectin-binding peptide. Arthritis Rheum 1999, 42:641-649.
16. Blum J., Handmaker H., Rinne N.A. Technetium labeled small peptide radiopharmaceuticals in the identification of lung cancer. Curr Pharm Des 2002, 8:1827-1836.
17. Okarvi S.M. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases. Med Res Rev 2004, 24:357-397.
18. Okarvi S.M. Recent developments in 99Tcm-labelled peptide-base radiopharmaceuticals: an overview. Nucl Med Commun 1999, 20:1093-1112.
19. Carmo V.A., Ferrari C.S., Reis E.C., Ramaldes G.A., Pereira M.A., De Oliveira M.C., et al. Biodistribution study and identification of inflammation sites using 99mTc-labelled stealth pH-sensitive liposomes. Nucl Med Commun 2008, 29:33-38.